Current strategy for medicating patients may be giving many drug-resistant diseases a big competitive advantage

In the war between drugs and drug-resistant diseases, the current strategy for medicating patients may be giving many drug-resistant diseases a big competitive advantage, according to a new article. The paper argues for new research efforts to discover effective ways for managing the evolution and slowing the spread of drug-resistant disease organisms.

Read the whole article on Science Daily

More from Science Daily